Literature DB >> 8919221

The place of endonasal endoscopy in the relief of middle turbinate sinonasal headache syndrome.

O El-Silimy1.   

Abstract

Middle turbinate sinonasal headache syndrome is a rare but not uncommon treatable cause of headache. The true incidence of headache from this cause is unknown. Pneumatization (concha bullosa) or hypertrophy of the middle turbinate can result in it contacting the septum or the lateral nasal wall and may give headaches in the periorbital region. It may occur in the absence of inflammatory sinus disease. The clinical history, nasal endoscopic examination and, coronal CT-scan should point towards the diagnosis and a local anaesthetic challenge test should confirm the diagnosis. Treatment is by relieving the contact point by medical or surgical means. Twenty-one cases of middle turbinate sinonasal headache syndrome refractory to medical treatment are presented with emphasis on the results of endonasal endoscopic surgical treatment.

Entities:  

Mesh:

Year:  1995        PMID: 8919221

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  4 in total

1.  In response to the 'Letter to the Editor' on the paper "Endoscopic surgical treatment for rhinogenic contact point headache: systematic review and meta-analysis".

Authors:  Antonino Maniaci; Salvatore Cocuzza; Giannicola Iannella; Ignazio La Mantia
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-16       Impact factor: 2.503

2.  Endoscopic approach to middle turbinate squeeze syndrome.

Authors:  Dipak Ranjan Nayak; Balakrishnan Ramaswamy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-12

Review 3.  Etiology of 'Sinus Headache'-Moving the Focus from Rhinology to Neurology. A Systematic Review.

Authors:  Marcin Straburzyński; Anna Gryglas-Dworak; Magdalena Nowaczewska; Eliza Brożek-Mądry; Paolo Martelletti
Journal:  Brain Sci       Date:  2021-01-09

4.  Effect of turbinoplasty in concha bullosa induced rhinogenic headache, a randomized clinical trial.

Authors:  Mohammad Ebrahim Yarmohammadi; Hassan Ghasemi; Shahryar Pourfarzam; Mohammad Reza Jalali Nadoushan; Siamak Afshin Majd
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.